Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 7/5/21 → 7/13/24 |
Funding
- Astellas Pharma Global Development Incorporated: $448,017.00
A Phase 1, Open-label Study of ASP9801, an Oncolytic Virus, Administered by Intratumoral Injection in Patients with Advanced/Metastatic Solid Tumors
- Villano, PhD, John (PI)
- Chauhan, Aman (Former PI)